LANCASTER COLONY CORP (LANC)       186.28  +0.06 (+0.03%)

186.28  +0.06 (+0.03%)

US5138471033 - Common Stock - After market: 186.28 0 (0%)


Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to LANC. LANC was compared to 105 industry peers in the Food Products industry. LANC has a great financial health rating, but there are some minor concerns on its profitability. LANC is quite expensive at the moment. It does show a decent growth rate.




Profitability

Profitability Rating

5

LANC's Return On Assets of 11.21% is amongst the best returns of the industry. LANC outperforms 91% of its industry peers. The industry average Return On Assets is 5.89%.
LANC's Return On Equity of 14.71% is in line with the rest of the industry. The industry average Return On Equity is 13.92%.

LANC's Profit Margin of 6.03% is in line with the rest of the industry. The industry average Profit Margin is 5.66%.
The Piotroski-F score of LANC is 6.00. This is a neutral score and indicates average health and profitability for LANC.
VS Industry

ROA (11.21%) VS Industry: 91% outperformed.

0.13
26.84

ROE (14.71%) VS Industry: 58% outperformed.

0.23
82.65

Profit Margin (6.03%) VS Industry: 55% outperformed.

0.08
41.73

Valuation

Valuation Rating

0

With a price book ratio of 5.95, LANC is valued correctly.
With a Price/Earnings Ratio of 32.85, LANC can be considered very expensive at the moment.
Compared to an average industry Price/Earning Ratio of 22.02, LANC is valued slightly more expensive.
With a Forward Price/Earnings Ratio of 25.18, LANC is valued very expensively.

The high PEG Ratio, which compensates the Price/Earnings for growth, indicates LANC does not grow enough to justify the current Price/Earnings ratio.
Compared to an average industry price book ratio of 1.91, LANC is valued more expensive than its industry peers. 94% of the companies listed in the same industry are valued cheaper.
When comparing the Enterprise Value to EBITDA ratio of LANC to the average industry ratio of 14.26, LANC is valued more expensive than its industry peers.
VS Industry

Price/Earnings (32.85) VS Industry: 30% outperformed.

549.00
5.52

Price/Book (5.95) VS Industry: 6% outperformed.

272.78
0.03

Enterprise Value/ EBITDA (20.93) VS Industry: 26% outperformed.

674.75
0.89

Growth

Growth Rating

5

The Earnings Per Share is expected to grow by 16.83% on average over the next 5 years. This is quite good.
When comparing the EPS growth rate of the last 5 years to the growth rate of the upcoming 5 years, we see that the growth is accelerating.
Looking at the last year, LANC shows a very strong growth in Revenue. The Revenue has grown by 39.22%.
LANC shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -5.50%.

The Earnings Per Share has been growing slightly by 3.34% on average over the past 5 years.
The Revenue has been growing slightly by 6.88% on average over the past 5 years.
Based on estimates for the next 5 years, LANC will show a small growth in Revenue. The Revenue will grow by 8.02% on average per year.
The Revenue growth is stable: in the next 5 years the growth will be about the same than in the last 5 years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS3.34% 2.18% -5.5% 16.16% 16.83% N/A N/A
Revenue6.88% 8.63% 39.22% 11.34% 8.02% N/A N/A

Health

Health Rating

7

The Quick Ratio of LANC is much better than the industry average of 0.90.
The Debt to Equity ratio of LANC is way better than the industry averages. LANC has a better rating than 91% of its industry peers.
LANC has an Altman-Z score of 15.93. This indicates that LANC is financially healthy and little risk of bankruptcy at the moment.
LANC has one of the better Altman-Z scores in its industry. It is much better than the industry average of 2.19. LANC has a better score than 97% of its industry peers.

A Current Ratio of 1.98 indicates that LANC should not have too much problems paying its short term obligations.
The Current Ratio is in line with the industry averages, which is at 1.80.
A Quick Ratio of 1.11 indicates that LANC should not have too much problems paying its short term obligations.
LANC has a Piotroski-F score of 6.00. This indicates an average health and profitability for LANC.
VS Industry

Debt/Equity (0) VS Industry: 91% outperformed.

53.34
0.00

Quick Ratio (1.11) VS Industry: 61% outperformed.

0.01
48.00

Current Ratio (1.98) VS Industry: 59% outperformed.

0.01
49.63

Altman-Z (15.93) VS Industry: 97% outperformed.

-34.87
76.82

Dividend

Dividend Rating

5

On average, the dividend of LANC grows each year by 7.30%, which is quite nice.
The dividend of LANC is growing, but earnings are growing more, so the dividend growth is sustainable.
LANC has paid a dividend for at least 10 years, which is a reliable track record.
With a Yearly Dividend Yield of 1.77%, LANC has a reasonable but not impressive dividend return.

Compared to an average industry Dividend Yield of 2.97, LANC's dividend is way lower than its industry peers. On top of this 87% of the companies listed in the same industry pay a better dividend than LANC!
LANC's Dividend Yield is slightly below the S&P500 average, which is at 2.41.
69.50% of the earnings are spent on dividend by LANC. This is not a sustainable payout ratio.
VS Industry

Dividend Yield (1.77%) VS Industry: 13% outperformed.

0.73
17.92

LANCASTER COLONY CORP186.28

NASDAQ:LANC (2/3/2023, 7:00:03 PM)+0.06 (+0.03%)

After market: 186.28 0 (0%)

Chartmill FA Rating
GICS Sector Consumer Staples
GICS IndustryGroup Food, Beverage & Tobacco
GICS Industry Food Products
Earnings (Last) 02-02 2023-02-02/amc Earnings (Next) 05-03 2023-05-03/amc
Inst Owners 60.84% Inst Owner Change -0.68%
Ins Owners 2.15% Ins Owner Change 2.97%
Market Cap 5.13B Analysts 50
Price Target 214.71 (15.26%)

Dividend
Industry RankSector Rank
Dividend Yield 1.77%
Dividend Growth(5Y) 7.3% DP 69.5%
Div Incr Years 6 Div Non Decr Years 6
Ex-Date N/A

Surprises & Revisions
EPS beat(2) 2 Avg EPS beat(2) 71.21%
Min EPS beat(2) 39.63% Max EPS beat(2) 102.8%
EPS beat(4) 2 Avg EPS beat(4) 31.52%
Min EPS beat(4) -13.38% Max EPS beat(4) 102.8%
Revenue beat(2) 1 Avg Revenue beat(2) 3.46%
Min Revenue beat(2) -1.04% Max Revenue beat(2) 7.96%
Revenue beat(4) 3 Avg Revenue beat(4) 24.93%
Min Revenue beat(4) -1.04% Max Revenue beat(4) 91.59%
PT rev (1m) 0% PT rev (3m) 26.05%
EPS NQ rev (1m) N/A EPS NQ rev (3m) N/A
EPS NY rev (1m) 0% EPS NY rev (3m) 13.67%
Revenue NQ rev (1m) N/A Revenue NQ rev (3m) N/A
Revenue NY rev (1m) 0% Revenue NY rev (3m) -0.62%

Valuation
Industry RankSector Rank
PE 32.85
Fwd PE 25.18
P/S 2.44
P/FCF 186.51
P/OCF 33.36
P/B 5.95
P/tB 8.25
EV/EBITDA 20.93
EPS(TTM) 5.67 EY 3.04%
EPS(NY) 7.4 Fwd EY 3.97%
FCF(TTM) 1 FCFY 0.54%
OCF(TTM) 5.58 OCFY 3%
SpS 76.29 BVpS 31.29
TBVpS 22.57 PEG (NY) 2.03
PEG (5Y) 9.85

Profitability
Industry RankSector Rank
ROA 11.21%
ROE 14.71%
ROIC 16.33%
ROICexc 17.52%
ROICexgc 24.14%
OM 9.34%
PM 6.03%
GM 21.64%
ROICexgc(3y) 28.12% ROICexcg growth 3Y -27.53%
ROICexcg growth 5Y -18.37% ROICexc(3y) 17.91%
ROICexc growth 3Y -19.54% ROICexc growth 5Y -13.52%
OM growth 3Y -15.84% OM growth 5Y -9.6%
PM growth 3Y -22.59% PM growth 5Y -11.06%
GM growth 3Y -5.25% GM growth 5Y -4.37%
F-Score 6 Asset Turnover 1.86

Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 275.7%
Profit Quality 21.7%
Current Ratio 1.98
Quick Ratio 1.11
Altman-Z 15.93
F-Score 6 WACC 8.03%
ROIC/WACC 3 Cap/Depr(3y) 234.14%
Cap/Depr(5y) 208.12% Profit Quality(3y) N/A
Profit Quality(5y) N/A

Growth
EPS 1Y -5.5% EPS 3Y 2.18%
EPS 5Y 3.34% EPS growth Q2Q 18.25%
EPS Next Y 16.16% EPS Next 2Y 16.83%
EPS Next 3Y N/A EPS Next 5Y N/A
Revenue growth 1Y 39.22% Revenue growth 3Y 8.63%
Revenue growth 5Y 6.88% Revenue growth Q2Q 8.54%
Revenue Next Year 11.34% Revenue Next 2Y 8.02%
Revenue Next 3Y N/A Revenue Next 5Y N/A
EBIT growth 1Y 10.69% EBIT growth 3Y -8.58%
EBIT growth 5Y -3.38% EBIT Next Year 114.29%
EBIT Next 3Y N/A EBIT Next 5Y N/A
FCF growth 1Y -72.62% FCF growth 3Y N/A
FCF growth 5Y N/A OCF growth 1Y -0.29%
OCF growth 3Y -19.83% OCF growth 5Y -7.01%

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA